Detalhe da pesquisa
1.
Inhaled Adjunct Therapy with Second-Line Drug Candidates for Dose Reduction in Chemotherapeutic Regimens for Multi-drug-Resistant Tuberculosis.
AAPS PharmSciTech
; 24(5): 130, 2023 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37291443
2.
Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics.
Int J Pharm
; 658: 124192, 2024 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38703931
3.
Mycobacteriophages: therapeutic approach for mycobacterial infections.
Drug Discov Today
; : 104049, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38830505